Cargando…
Drug Delivery of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) to Target Brain Tumors
Brain, predisposed to local and metastasized tumors, has always been the focus of oncological studies. Glioblastoma multiforme (GBM), the most common invasive primary tumor of the brain, is responsible for 4% of all cancer-related deaths worldwide. Despite novel technologies, the average survival ra...
Autor principal: | Mehrdadi, Soheil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tabriz University of Medical Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460802/ https://www.ncbi.nlm.nih.gov/pubmed/37646057 http://dx.doi.org/10.34172/apb.2023.062 |
Ejemplares similares
-
Evaluation and Comparison of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) as Vectors to Develop Hydrochlorothiazide Effective and Safe Pediatric Oral Liquid Formulations
por: Mura, Paola, et al.
Publicado: (2021) -
Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies
por: Elmowafy, Mohammed, et al.
Publicado: (2021) -
Nanostructured Lipid Carriers (NLCs) for Oral Peptide Drug Delivery: About the Impact of Surface Decoration
por: Shahzadi, Iram, et al.
Publicado: (2021) -
Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB
por: Satapathy, Mantosh Kumar, et al.
Publicado: (2021) -
Atorvastatin-loaded nanostructured lipid carriers (NLCs): strategy to overcome oral delivery drawbacks
por: Elmowafy, Mohammed, et al.
Publicado: (2017)